Choksi Laboratories [CHOKSILA] vs Dr. Lal PathLabs [LALPATHLAB] Detailed Stock Comparison

Choksi Laboratories

BSE

Dr. Lal PathLabs

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Choksi Laboratories wins in 6 metrics, Dr. Lal PathLabs wins in 12 metrics, with 0 ties. Dr. Lal PathLabs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Choksi Laboratories	Dr. Lal PathLabs	Better
P/E Ratio (TTM)	101.93	55.99	Dr. Lal PathLabs
Price-to-Book Ratio	6.63	13.24	Choksi Laboratories
Debt-to-Equity Ratio	123.52	7.14	Dr. Lal PathLabs
PEG Ratio	N/A	2.32	N/A
EV/EBITDA	16.17	40.07	Choksi Laboratories
Profit Margin (TTM)	3.52%	20.29%	Dr. Lal PathLabs
Operating Margin (TTM)	10.90%	23.54%	Dr. Lal PathLabs
EBITDA Margin (TTM)	10.90%	23.54%	Dr. Lal PathLabs
Return on Equity	6.45%	22.08%	Dr. Lal PathLabs
Return on Assets (TTM)	2.33%	17.93%	Dr. Lal PathLabs
Free Cash Flow (TTM)	$40.91M	$5.15B	Dr. Lal PathLabs
Dividend Yield	N/A	0.93%	N/A
1-Year Return	191.98%	2.15%	Choksi Laboratories
Price-to-Sales Ratio (TTM)	3.69	11.39	Choksi Laboratories
Enterprise Value	$1.86B	$272.59B	Dr. Lal PathLabs
EV/Revenue Ratio	4.39	10.78	Choksi Laboratories
Gross Profit Margin (TTM)	85.53%	66.99%	Choksi Laboratories
Revenue per Share (TTM)	$61	$303	Dr. Lal PathLabs
Earnings per Share (Diluted)	$2.20	$61.63	Dr. Lal PathLabs
Beta (Stock Volatility)	0.16	0.08	Dr. Lal PathLabs

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Choksi Laboratories vs Dr. Lal PathLabs Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Choksi Laboratories	-0.34%	-1.92%	15.70%	98.51%	73.94%	144.17%
Dr. Lal PathLabs	-0.25%	-1.57%	12.35%	19.67%	30.32%	10.54%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Choksi Laboratories	191.98%	677.21%	1,917.89%	1,529.26%	937.50%	199.25%
Dr. Lal PathLabs	2.15%	28.00%	83.35%	276.64%	276.64%	276.64%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Choksi Laboratories (CHOKSILA): View Full Stock Overview

Dr. Lal PathLabs (LALPATHLAB): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Choksi Laboratories vs Dr. Lal PathLabs

Metric	CHOKSILA	LALPATHLAB
Market Information
Market Cap i	₹1.56B	₹287.98B
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	14,560	104,131
90 Day Avg. Volume i	10,119	134,770
Last Close	₹219.95	₹3,374.90
52 Week Range	₹56.16 - ₹236.70	₹2,293.55 - ₹3,653.95
% from 52W High	-7.08%	-7.64%
All-Time High	₹236.70 (Aug 20, 2025)	₹4,245.50 (Sep 13, 2021)
% from All-Time High	-7.08%	-20.51%
Growth Metrics
Quarterly Revenue Growth	0.05%	0.11%
Quarterly Earnings Growth	-0.09%	0.24%
Financial Health
Profit Margin (TTM) i	0.04%	0.20%
Operating Margin (TTM) i	0.11%	0.24%
Return on Equity (TTM) i	0.06%	0.22%
Debt to Equity (MRQ) i	123.52	7.14
Cash & Liquidity
Book Value per Share (MRQ)	₹33.82	₹260.62
Cash per Share (MRQ)	₹0.88	₹139.63
Operating Cash Flow (TTM) i	₹51.38M	₹4.66B
Levered Free Cash Flow (TTM) i	₹15.23M	₹4.87B
Dividends
Last 12-Month Dividend Yield i	N/A	0.93%
Last 12-Month Dividend i	N/A	₹30.00

Valuation & Enterprise Metrics Analysis: Choksi Laboratories vs Dr. Lal PathLabs

Metric	CHOKSILA	LALPATHLAB
Price Ratios
P/E Ratio (TTM) i	101.93	55.99
Forward P/E i	N/A	117.46
PEG Ratio i	N/A	2.32
Price to Sales (TTM) i	3.69	11.39
Price to Book (MRQ) i	6.63	13.24
Market Capitalization
Market Capitalization i	₹1.56B	₹287.98B
Enterprise Value i	₹1.86B	₹272.59B
Enterprise Value Metrics
Enterprise to Revenue i	4.39	10.78
Enterprise to EBITDA i	16.17	40.07
Risk & Other Metrics
Beta i	0.16	0.08
Book Value per Share (MRQ) i	₹33.82	₹260.62

Financial Statements Comparison: Choksi Laboratories vs Dr. Lal PathLabs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	CHOKSILA	LALPATHLAB
Revenue/Sales i	₹114.00M	₹6.70B
Cost of Goods Sold i	₹16.49M	₹2.21B
Gross Profit i	₹97.50M	₹4.49B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹18.64M	₹1.58B
EBITDA i	₹35.45M	₹2.20B
Pre-Tax Income i	₹12.59M	₹1.81B
Income Tax i	₹3.38M	₹471.00M
Net Income (Profit) i	₹9.21M	₹1.34B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	CHOKSILA	LALPATHLAB
Cash & Equivalents i	₹6.12M	₹2.93B
Total Current Assets i	₹163.21M	₹13.64B
Total Current Liabilities i	₹238.75M	₹4.02B
Long-Term Debt i	₹159.63M	₹1.03B
Total Shareholders Equity i	₹236.05M	₹22.06B
Retained Earnings i	N/A	₹18.60B
Property, Plant & Equipment i	₹471.35M	₹3.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	CHOKSILA	LALPATHLAB
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	CHOKSILA	LALPATHLAB
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	14,560	104,131
Average Daily Volume (90 Day) i	10,119	134,770
Shares Outstanding i	6.97M	83.37M
Float Shares i	3.37M	37.19M
% Held by Insiders i	0.56%	0.57%
% Held by Institutions i	0.00%	0.32%

Dividend Analysis & Yield Comparison: Choksi Laboratories vs Dr. Lal PathLabs

Metric	CHOKSILA	LALPATHLAB
Last 12-Month Dividend i	N/A	₹30.00
Last 12-Month Dividend Yield i	N/A	0.93%
3-Year Avg Annual Dividend i	N/A	₹20.00
3-Year Avg Dividend Yield i	N/A	0.28%
3-Year Total Dividends i	N/A	₹60.00
Ex-Dividend Date	N/A	Aug 06, 2025

Choksi Laboratories [CHOKSILA] vs Dr. Lal PathLabs [LALPATHLAB] Detailed Stock Comparison